HYAC News and Press, Haymaker Acquisition Corp.

Business combination with Haymaker Acquisition Corp. III complete biote Corp.’s common stock will trade on the Nasdaq Stock Exchange under ticker symbol “BTMD” biote Corp., (Nasdaq: BTMD) (“Biote” or the “Company ...

Shareholders of SPAC Haymaker Acquisition Corp. III (HYAC) have voted in favor of a proposed merger with hormone therapy provider Biote (BTMD). Haymaker said it expects the closing to take place on May 26, with shares opening for trade on May 27. The stock will trade on Nasdaq under the symbo...

NEW YORK, May 24, 2022 (GLOBE NEWSWIRE) -- Haymaker Acquisition Corp. III (Nasdaq: HYAC) (“Haymaker” or the “Company”), a publicly traded special purpose acquisition company, today announced that its stockholders voted to approve the previously announced business...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

NEW YORK, May 17, 2022 (GLOBE NEWSWIRE) -- Haymaker Acquisition Corp. III (Nasdaq: HYAC) (“Haymaker” or the "Company"), a publicly traded special purpose acquisition company, reminds its shareholders to vote in favor of the proposed business combination with BioTE Holdings, LL...

Company accelerates expansion and reiterates 2022 guidance Net sales of $37 million in the quarter, an 18% increase year-over-year from the first quarter of 2021. First quarter procedural revenue grew at 21.2% year-over-year. Adjusted EBITDA of $12 million, a 20% incre...

Record net sales of $139.4 million for the full year, a 20% increase year-over-year. Record net sales of $37.5 million in the fourth quarter, a 22% increase period-over-period. EBITDA of $36 million, a 9% increase year-over-year.¹ In December 2021, Biote entered into a bu...

The acquisition of Arena Pharmaceuticals by Pfizer for $4.69 billion. The announcement to acquire Arena comes less than a month after Pfizer closed another $2.2 billion deal. Bottomline Technologies (EPAY), a potential deal in the works, signed a merger agreement with Thoma Bravo....

SPAC Haymaker Acquisition III (NASDAQ:HYAC) rose 1% after agreeing to to take hormone therapy company Biote Holdings LLC in a deal that will value the company at about $737M. Biote is expected to have about $195M in cash on its balance sheet after closing, according to a statement. ...

NEW YORK, April 19, 2021 (GLOBE NEWSWIRE) -- Haymaker Acquisition Corp. III (NASDAQ: HYACU) (the “Company”) today announced that, commencing April 22, 2021, holders of the units sold in the Company’s initial public offering may elect to separately trade the shares of th...